ARTICLE | Company News
Elan, Wyeth-Ayerst Research deal
February 7, 2000 8:00 AM UTC
The partners will develop small molecule inhibitors of the cell adhesion integrin Alpha4Beta1 to treat inflammatory and autoimmune disorders. ELN received an initial payment and could receive mileston...